GSK plc (LON:GSK – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,444 ($18.73) and traded as high ...

Atria Investments Inc cut its holdings in GSK plc (NYSE:GSK – Free Report) by 7.6% in the fourth quarter, according to the ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.

could cause cancer were “admissible”, sparking a sell-off in GSK shares that wiped billions off its market cap. Now, the drugmaker and co-defendants, including Pfizer, Sanofi, and Boehringer ...

Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.

GSK PLC closed 15.88% below its 52-week high of £18.24, which the company reached on May 16th.

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... In a similar vein, the market has grown significantly due to consumer interest in weight-loss medications like Ozempic ...